Tessera Therapeutics Alternatives & Competitors
12 companies similar to Tessera Therapeutics — Pioneering the future of genetic medicine with the power to rewrite the genome a...
Companies similar to Tessera Therapeutics
Nephrogen
Curative gene therapies for kidney diseases
New York, United States
EmendoBio
Making any gene targetable
New York, United States
HuidaGene Therapeutics
辉大，给患者回答 | Answering the Patients！
Shanghai, China
BreezeBio
Genetic Medicine Delivered
Brisbane, United States
Rival Readout
Competing with Tessera Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Prime Medicine, Inc.
Delivering on the promise of Prime Editing
Cambridge, United States
Italy
ReNAgade Therapeutics
RNA Without Limits
Cambridge, United States
Chameleon Biosciences, Inc.
Saving children's lives, one genetic disease at a time.
SonoThera
SonoThera is developing ultrasound-mediated nonviral genetic therapies.
South San Francisco, Unit...
Acrigen Biosciences
Developing life-saving genetic therapies using our proprietary precision gene editing tech...
Alameda, United States
Vedere Bio II
Bringing vision back to life.
Cambridge, United States
Carbon Biosciences
Expanding Therapeutic Potential with Novel Parvovirus Gene Therapy
Boston, United States
About Tessera Therapeutics
Tessera Therapeutics, founded in 2018, is at the forefront of the life sciences sector with its pioneering Gene Writing technology. As an innovation by Flagship Pioneering, this company is positioned to redefine the realm of genetic medicine by enabling the rewriting of the genome to cure diseases at their root cause....
Development of Gene Writing Technology, Non-Viral Delivery Solutions, Preclinical Research and Data Presentation, Therapeutic Innovation for Genetic Disorders
Biopharmaceutical Companies, Healthcare Providers, Medical Researchers, Patients with Genetic Disorders
Gene Writing, Genetic Medicine, Genome Editing, Therapeutic Genome Modification, Disease Cure Technology, Life Sciences, Healthcare Innovation, Gene Therapy Advancement, Genomic Research, Medical Biotechnology, Therapeutic Instruction Insertion, Root Cause Disease Treatment, Biopharmaceutical Innovation, Healthcare Sector Pioneering
B2B, Platform, B2B2C
Licensing, Performance Based, Project Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Tessera Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Tessera Therapeutics on 15 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
